CompuGroup Medical has entered into a strategic partnership agreement with CVC Capital Partners and GT1 Vermögensverwaltung GmbH, the main shareholder of CompuGroup. This collaboration with CVC is contingent upon a holding company, advised and managed by CVC Capital Partners affiliates, successfully finalizing a voluntary public tender offer to acquire all outstanding CompuGroup shares at 22.00 euros per share in cash. Once the offer is completed, the strategic partners, along with the founding family Gotthardt and associated shareholder Koop, will collectively own at least 67% of the total shares.
The board of CompuGroup Medical Management SE, alongside the Supervisory Board, intends to endorse the acceptance of this offer. The acceptance period is anticipated to commence by the end of December 2024, with the transaction expected to close in the first half of 2025. Following the successful tender offer, CompuGroup Medical's management and CVC have decided to take the company private through a delisting initiative.
